The bacterial superantigen staphylococcal enterotoxin A (SEA) is an extremely potent
activator of T lymphocytes when presented on MHC class II antigens. In order to induce T …

The bacterial superantigen staphylococcal enterotoxin A (SEA) is an extremely potent
activator of T lymphocytes when presented on major histocompatibility complex (MHC) class …

We have recently demonstrated that the superantigen staphylococcal enterotoxin A (SEA)
targets in vitro activated cytotoxic T lymphocytes against tumor cells expressing major …

The bacterial superantigen staphylococcal enterotoxin (SE) A (SEA) directs cytotoxic T
lymphocytes (CTLs) expressing particular sequences of the T-cell receptor (TCR) beta chain …

Previous work demonstrated that human cytotoxic T cells activated by superantigens can
lyse major histocompatibility complex (MHC) class II‐positive target cells as well as MHC …

Monoclonal antibodies have a potential for cancer therapy that may be further improved by
linking them to effector molecules such as superantigens. Tumor targeting of a superantigen …

T lymphocytes generally fail to recognize human colon carcinomas, suggesting that the
tumour is beyond reach of immunotherapy. Bacterial superantigens are the most potent …

The bacterial superantigen staphylococcal enterotoxin A (SEA) induces T cell activation as
well as directing activated T cells to kill major-histocompatibilitycomplex-class-II-expressing …

We have developed a monoclonai antibody (mAb) based therapy intended for the treatment
ofsolid tumors utilizing both main arms of the immune system by incorporating the colon …

CTLs bearing certain T-cell receptor Vβ-regions are directed by the bacterial superantigen
Staphylococcus enterotoxin A (SEA) to lyse MHC class II-positive cells. In order to extend …